Navigation Links
Beth Israel Deaconess Medical Center, Harvard Medical School Study Confirms Cannabis Science's Approach to Development of CS-TATI-1 to Inhibit Kaposi Sarcoma
Date:11/12/2012

inhabitants of sub-Saharan Africa, and immunocompromised individuals such as organ transplant recipients and AIDS patients. Current treatments for Kaposi sarcoma can inhibit tumor growth but are not able to eliminate KSHV from the host. When the host's immune system weakens, KSHV begins to replicate again, and active tumor growth ensues. New therapeutic approaches are needed. Cannabidiol (CBD), a plant-derived cannabinoid, exhibits promising antitumor effects without inducing psychoactive side effects. CBD is emerging as a novel therapeutic for various disorders, including cancer. In this study, we investigated the effects of CBD both on the infection of endothelial cells (ECs) by KSHV and on the growth and apoptosis of KSHV-infected ECs, an in vitro model for the transformation of normal endothelium to Kaposi sarcoma. While CBD did not affect the efficiency with which KSHV infected ECs, it reduced proliferation and induced apoptosis in those infected by the virus. CBD inhibited the expression of KSHV viral G protein–coupled receptor (vGPCR), its agonist, the chemokine growth-regulated protein α (GRO-α), vascular endothelial growth factor receptor 3 (VEGFR-3), and the VEGFR-3 ligand, vascular endothelial growth factor C (VEGF-C). This suggests a potential mechanism by which CBD exerts its effects on KSHV-infected endothelium and supports the further examination of CBD as a novel targeted agent for the treatment of Kaposi Sarcoma.

About CS-TATI-1

Cannabis Science's research of CS-TATI-1 will be targeted to newly diagnosed patients infected with drug resistant virus, treatment experienced patients with drug-resistant HIV strains, and those intolerant of currently available therapies. Cannabis Science will be pursuing a wide range of NIH based Federal Research Programs such as RO1's, PO1's and SBIRS which exist to support preclinical development of target validation and proof of concept studies. These studies will be implemented through co
'/>"/>

SOURCE Cannabis Science, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Israel Makov Appointed Chairman of Sun Pharma Board
2. Cephasonics Inks Distribution Deal With Tritech To Extend Worldwide Sales Reach Into Israel
3. Oramed Pharmaceuticals to Present at the 11th National Life Science & Technology Week ILSI-BIOMED Conference; Tel Aviv, Israel, 2012
4. Medical Device Study Presents Detailed View of Key Budget and Staffing Metrics for Marketing Groups
5. QUANTEL Medical Signs Global Licensing Agreement with IRIDEX
6. Sony Medical Division Teams with Wills Eye Institute to Bring "Expert" Panel of Ophthalmologists to AAO 2012 Convention
7. STD Med Inc. Receives ANVISA Registration for Class III Medical Devices in Brazil
8. Mount Sinai Medical Center 1st in Tri-State Area to Discharge Patient without Human Heart
9. Concord Medical Announces Change to Third Quarter Financial Results Date to November 20, 2012
10. Winner Medical Announces Mailing of Definitive Proxy Materials for Special Meeting of Shareholders
11. UBM Canon, lacteur qui fait autorité dans le secteur des technologies médicales, annonce une embauche clé en Allemagne pour compléter son équipe en pleine expansion travaillant sur les solutions médias et marketing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... -- Integrated Silicon Solution, Inc. (Nasdaq: ISSI ... solutions, today announced that it will host its earnings ... a.m. Pacific Time (10:00 a.m. Eastern Time) to discuss ... quarter ended June 30, 2014. To access ... a.m. Pacific time on July 24, 2014.  The participant ...
(Date:7/10/2014)... , July 10, 2014  BC Technical, the largest ... MiE America , Inc., a leading provider of Siemens ... a long-term agreement naming BC Technical as the authorized ... MiE and BC Technical announced today that ... establish BC Technical as the service and systems provider ...
(Date:7/10/2014)... July 10, 2014  Decision Resources Group finds ... disease (ID) specialists are willing to prescribe Durata,s ... for use as OPAT, approximately two-thirds of the ... to their hospital inpatients. However, our findings indicate ... are initiated on OPAT following hospital discharge, and ...
Breaking Medicine Technology:BC Technical Partners With MiE America To Be Authorized Provider Of Systems & Service 2Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 2Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 3
(Date:7/11/2014)... FRIDAY, July 11, 2014 (HealthDay News) -- Children ... greater risk for complications and potentially even death ... a new study. However, the Johns Hopkins ... "miniscule." The researchers analyzed data on nearly ... United States underwent over a 22-year period. ...
(Date:7/11/2014)... July 11, 2014 According to a ... Application Market by Communication Technology (ZigBee, Z-Wave, Bluetooth, Wi-Fi, ... Industrial, Automotive & Transportation, Agriculture) & Geography - Global ... of Internet of Things market was worth $1029.5 Billion ... by 2020, at an estimated CAGR of 4.08% from ...
(Date:7/11/2014)... -- Researchers from The Miriam Hospital have found ... have significantly higher rates of smoking than those ... were less likely to attempt quitting than those ... not be sufficient for this population. The study ... of print in the American Journal of ...
(Date:7/11/2014)... Steven Reinberg HealthDay Reporter ... to protect children from the worldwide scourge of dengue fever ... While the vaccine only prevented dengue fever in 56 percent ... three shots, it protected more than 88 percent of them ... lead to hospitalization, and sometimes death. "This vaccine has ...
(Date:7/11/2014)... Last month Watkins Insurance Group introduced ... the agency as a specialist in insurance and bonding ... Bachelor’s Degree in Business Administration from Texas State University. ... manage everything from performance and payment bonds, license and ... needs for those in the asphalt supplier industry. In ...
Breaking Medicine News(10 mins):Health News:Emergency Surgeries on Weekends Riskier for Kids: Study 2Health News:Internet of Things Technology & Application Market Worth $1423.09 Billion by 2020 – New Report by MarketsandMarkets 2Health News:Internet of Things Technology & Application Market Worth $1423.09 Billion by 2020 – New Report by MarketsandMarkets 3Health News:Internet of Things Technology & Application Market Worth $1423.09 Billion by 2020 – New Report by MarketsandMarkets 4Health News:Miriam Hospital study examines smoking prevalence 2Health News:Dengue Fever Vaccine Shows Some Promise in Trial 2Health News:Dengue Fever Vaccine Shows Some Promise in Trial 3
... Office-based, surgeon-performed, ultrasound-guided, fine needle aspiration (FNA) of head ... rate compared to the standard palpation technique, indicates new ... Head and Neck Surgery . FNA ... or masses. In this technique, a thin, hollow needle ...
... Spanish researchers determined that rats treated with recombinant ghrelin displayed ... reduced the amount of fibrogenic cells by 25% in the ... liver damage and reduced oxidative stress and inflammation in the ... the March issue of Hepatology , a journal of ...
... ... ... ... ...
... Survey ... ... an estimated 12 million Americans, yet according to a survey of 1,000 people conducted by ... and saw the benefits of undergoing genetic testing, close to 80 percent had never talked ...
... finds , SUNDAY, Feb. 28 (HealthDay News) -- Exposure to ... of developing asthma, researchers say. , "In an earlier study, ... endotoxin and allergens [mite and cockroach] in their day-care centers. ... cohort study, if infants from low-income families with high risk ...
... ... ... ... ...
Cached Medicine News:Health News:Office-based ultrasound-guided FNA superior in diagnosing head and neck lesions 2Health News:Ghrelin mitigates liver fibrosis in animal models; regulates human fibrosis 2Health News:Ghrelin mitigates liver fibrosis in animal models; regulates human fibrosis 3Health News:Multiple Medalist Kristina Groves Matches Hain Celestial's $5,000 Donation to Right to Play 2Health News:Multiple Medalist Kristina Groves Matches Hain Celestial's $5,000 Donation to Right to Play 3Health News:Multiple Medalist Kristina Groves Matches Hain Celestial's $5,000 Donation to Right to Play 4Health News:Multiple Medalist Kristina Groves Matches Hain Celestial's $5,000 Donation to Right to Play 5Health News:Multiple Medalist Kristina Groves Matches Hain Celestial's $5,000 Donation to Right to Play 6Health News:Multiple Medalist Kristina Groves Matches Hain Celestial's $5,000 Donation to Right to Play 7Health News:Multiple Medalist Kristina Groves Matches Hain Celestial's $5,000 Donation to Right to Play 8Health News:Genetic Disease Foundation Encourages Americans to Know Their Genes at KnowYourGenes.org in Observance of World Rare Disease Day 2Health News:Genetic Disease Foundation Encourages Americans to Know Their Genes at KnowYourGenes.org in Observance of World Rare Disease Day 3Health News:Genetic Disease Foundation Encourages Americans to Know Their Genes at KnowYourGenes.org in Observance of World Rare Disease Day 4Health News:Household Dirt Won't Raise Asthma Risk in Infants 2Health News:CareTech Solutions Honors Five Hospitals with Rising Star Awards 2Health News:CareTech Solutions Honors Five Hospitals with Rising Star Awards 3Health News:CareTech Solutions Honors Five Hospitals with Rising Star Awards 4Health News:CareTech Solutions Honors Five Hospitals with Rising Star Awards 5
The MACS VA_500 (variable atmosphere) is primarily for the study and isolation of microaerophilic organisms,including Campylobacter spp,Helicobacter pylori and other similarly fastdious organisms....
Lose the variability of anaerobic jars and step into the 21st century with the anaerobic workstation that provides the answer to the common problems associated with anaerobic microbiology....
... is the most versatile orthopedic/trauma ... designed for both lower body ... an integrated shoulder attachment. The ... operating table for your most ...
... With MARS, the operating theatre is ready for ... surgical fields. Its modern design allows a quick, ... The individual components are connected securely and sturdily ... system. And if there should ever be a ...
Medicine Products: